R Alsarraf1, C J Jung, J Perkins, C Crowley, N W Alsarraf, G A Gates. 1. Department of Otolaryngology-Head and Neck Surgery, University of Washington School of Medicine and Virginia Merrill Bloedel Hearing Research Center, Seattle 98195, USA. amro@u.washington.edu
Abstract
OBJECTIVES: To test a method of measuring the related cost of acute otitis media (AOM) and to provide a preliminary calculation of the indirect and directs costs associated with a single, medically treated episode of AOM. DESIGN: The Otitis Media Diary was used to measure indirect and direct costs associated with AOM in a prospective cohort study. Measured values included the parental time spent in otitis-specific child care and the number and type of medications used. A previously developed economic model was used to calculate the monetary costs associated with the value of caregiver time and the total opportunity cost of AOM. SETTING: The pediatric clinic of Madigan Army Medical Center, Tacoma, Wash. PATIENTS: A cohort of 25 children (12 with AOM and 13 controls) aged 1 to 3 years. MAIN OUTCOME MEASURES: Caregiver time and medication use. RESULTS: The total cost attributable to AOM in the 3-month period following diagnosis was $1330.58 (95% confidence interval, $1008.75-$1652.43), with the majority of that cost stemming from the indirect, rather than direct, costs of illness. After conservative estimates of unmeasured expenses, such as clinic visits and transportation, were accounted for, indirect costs, accrued primarily by parental time, accounted for nearly 90% (95% confidence interval, 87.1%-92.3%) of the total 3-month cost associated with AOM and its medical treatment. The cost items of the Otitis Media Diary were also highly correlated with each other and with other measures of clinical and functional health status. CONCLUSIONS: Otitis Media Diary measures of parental time and medication use appear to provide a more accurate means of calculating the real social costs attributable to the AOM disease process in this cost-effectiveness analysis.
OBJECTIVES: To test a method of measuring the related cost of acute otitis media (AOM) and to provide a preliminary calculation of the indirect and directs costs associated with a single, medically treated episode of AOM. DESIGN: The Otitis Media Diary was used to measure indirect and direct costs associated with AOM in a prospective cohort study. Measured values included the parental time spent in otitis-specific child care and the number and type of medications used. A previously developed economic model was used to calculate the monetary costs associated with the value of caregiver time and the total opportunity cost of AOM. SETTING: The pediatric clinic of Madigan Army Medical Center, Tacoma, Wash. PATIENTS: A cohort of 25 children (12 with AOM and 13 controls) aged 1 to 3 years. MAIN OUTCOME MEASURES: Caregiver time and medication use. RESULTS: The total cost attributable to AOM in the 3-month period following diagnosis was $1330.58 (95% confidence interval, $1008.75-$1652.43), with the majority of that cost stemming from the indirect, rather than direct, costs of illness. After conservative estimates of unmeasured expenses, such as clinic visits and transportation, were accounted for, indirect costs, accrued primarily by parental time, accounted for nearly 90% (95% confidence interval, 87.1%-92.3%) of the total 3-month cost associated with AOM and its medical treatment. The cost items of the Otitis Media Diary were also highly correlated with each other and with other measures of clinical and functional health status. CONCLUSIONS:Otitis Media Diary measures of parental time and medication use appear to provide a more accurate means of calculating the real social costs attributable to the AOM disease process in this cost-effectiveness analysis.
Authors: Glen McGillivary; William C Ray; Charles L Bevins; Robert S Munson; Lauren O Bakaletz Journal: Mol Immunol Date: 2006-11-20 Impact factor: 4.407
Authors: John M Atack; Linda E Winter; Joseph A Jurcisek; Lauren O Bakaletz; Stephen J Barenkamp; Michael P Jennings Journal: J Infect Dis Date: 2015-02-23 Impact factor: 5.226
Authors: Kyle A Murrah; Roberta L Turner; Bing Pang; Antonia C Perez; Jennifer L Reimche; Lauren B King; John Wren; Uma Gandhi; W Edward Swords; David A Ornelles Journal: Pathog Dis Date: 2015-02-26 Impact factor: 3.166
Authors: John M Atack; Christopher J Day; Jessica Poole; Kenneth L Brockman; Lauren O Bakaletz; Stephen J Barenkamp; Michael P Jennings Journal: Biochem Biophys Res Commun Date: 2018-06-27 Impact factor: 3.575
Authors: Robert S Munson; Alistair Harrison; Allison Gillaspy; William C Ray; Matt Carson; David Armbruster; Jenny Gipson; Mandy Gipson; Linda Johnson; Lisa Lewis; David W Dyer; Lauren O Bakaletz Journal: Infect Immun Date: 2004-05 Impact factor: 3.441